MAIA Biotechnology, Inc. (MAIA) vs Rein Therapeutics Inc. (RNTX)

MAIA Biotechnology, Inc. and Rein Therapeutics Inc. are both Biotechnology companies. MAIA Biotechnology, Inc. and Rein Therapeutics Inc. are of similar size ($76.0M and $73.8M). Across the 8 metrics below, MAIA Biotechnology, Inc. leads on 5 and Rein Therapeutics Inc. on 3.

Valuation

Metric MAIA RNTX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 3.53 4.93 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (52.48%) (229.33%) (28.84%)
Free cash flow yield (30.94%) (37.22%) (23.03%)

Profitability

Metric MAIA RNTX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (218.68%) (753.55%) (57.72%)
Return on assets (136.67%) (80.62%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MAIA RNTX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 33.33% 44.16% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MAIA RNTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.51 4.27 4.73
Net debt to EBITDA 0.36 0.15 0.96

Dividend

Metric MAIA RNTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric MAIA RNTX Biotechnology median
Market cap 76.04m 73.80m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack